Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.219
EU - Europa 5.610
AS - Asia 3.249
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 18
AF - Africa 16
Totale 19.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.024
SG - Singapore 1.242
IT - Italia 1.170
CN - Cina 1.046
DE - Germania 1.020
SE - Svezia 822
IE - Irlanda 693
RU - Federazione Russa 584
UA - Ucraina 463
HK - Hong Kong 295
GB - Regno Unito 284
CA - Canada 189
VN - Vietnam 150
ID - Indonesia 149
FI - Finlandia 131
AT - Austria 107
FR - Francia 98
KR - Corea 94
IN - India 92
DK - Danimarca 84
JP - Giappone 58
TR - Turchia 54
BE - Belgio 42
NL - Olanda 37
TW - Taiwan 25
PL - Polonia 22
EU - Europa 18
IR - Iran 18
AU - Australia 14
NZ - Nuova Zelanda 14
EG - Egitto 12
ES - Italia 11
BR - Brasile 8
BG - Bulgaria 7
CH - Svizzera 7
IL - Israele 6
PE - Perù 6
RO - Romania 6
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
MX - Messico 4
PH - Filippine 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HR - Croazia 3
IQ - Iraq 3
RS - Serbia 3
SC - Seychelles 3
CL - Cile 2
CO - Colombia 2
GT - Guatemala 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PK - Pakistan 2
BD - Bangladesh 1
EE - Estonia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 19.158
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.831
Singapore 1.055
Dublin 676
Chandler 666
Woodbridge 649
Frankfurt am Main 612
Wilmington 532
Milan 463
Jacksonville 458
Dearborn 453
Houston 409
Fairfield 405
Ashburn 361
New York 312
Santa Clara 305
Princeton 271
Hong Kong 255
Nanjing 196
Seattle 177
Boardman 165
Jakarta 148
Shanghai 137
Cambridge 124
Vienna 100
Beijing 82
Dong Ket 74
Lachine 74
Guangzhou 72
Lawrence 67
Nanchang 67
Altamura 61
Shenyang 54
Andover 49
Helsinki 47
Fremont 43
Jinan 41
Toronto 40
Pune 36
Melzo 35
Ottawa 34
San Diego 34
Brussels 33
Chicago 33
Falls Church 32
Rome 32
Tianjin 31
Hangzhou 30
Zhengzhou 28
Los Angeles 27
Daejeon 26
Changsha 25
Jiaxing 25
Kunming 25
London 24
Nürnberg 23
Grafing 21
Norwalk 21
Sacramento 21
Hebei 20
Shangdi 20
Bergamo 19
Dallas 19
Mountain View 17
Seoul 17
Edmonton 16
San Antonio 16
Tokyo 16
Kocaeli 15
Leawood 15
Ningbo 15
Carate Brianza 14
Hefei 14
Kiev 14
Lissone 14
Munich 13
Phoenix 13
Codroipo 12
Shinjuku 12
Kraków 11
Washington 11
Florence 10
Kaohsiung 10
Taizhou 10
Cagliari 9
Mainz 9
Monza 9
Bologna 8
Boston 8
Buffalo 8
Chengdu 8
Fuzhou 8
Wuhan 8
Ankara 7
Canazei 7
Changchun 7
Lappeenranta 7
Paris 7
San Mateo 7
Sesto San Giovanni 7
Suwon 7
Totale 13.621
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 305
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 300
Age-related changes in the function and structure of the peripheral sensory pathway in mice 297
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 289
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 284
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 248
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 236
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 232
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 218
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 213
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 211
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 209
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 208
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 205
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 205
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 200
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 200
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 199
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 197
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 197
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 192
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 186
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 185
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 185
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 180
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 178
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 176
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 174
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 172
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 171
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 170
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 169
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 168
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 165
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 163
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 157
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 155
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 154
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 153
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 152
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 151
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 151
Granulocytes in actively induced Lewis rat EAE 150
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 149
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 144
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 140
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 136
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 135
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 135
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 132
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 132
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 131
Multimodal experimental approach to the study of human neurological diseases 130
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
MSCs effect on Dark Agouti rats affected by chronic EAE 129
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 129
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 128
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 128
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 128
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 128
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 128
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 128
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 127
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 126
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 125
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 125
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 125
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 122
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 119
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 118
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 117
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 116
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 116
Pharmacokinetics of IVIg in Wistar rats 115
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 112
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 112
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 110
Methylene blue protects against paclitaxel-induced peripheral neurotoxicity 109
Caratterizzazione dell'effetto analgesico di un nuovo ligando del recettore I2 imidazolinico in un modello animale di dolore neuropatico indotto da bortezomib 107
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice 107
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 106
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 105
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 102
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 102
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 102
Clinical and preclinical features of eribulin-related peripheral neuropathy 102
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 101
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 101
Totale 15.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.768 0 0 0 0 0 362 486 178 247 254 199 42
2020/20213.099 128 88 317 297 247 275 334 313 292 261 220 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.991 376 737 335 270 222 486 42 144 223 43 76 37
2023/20242.539 83 65 69 89 329 590 408 114 148 53 45 546
2024/20253.337 422 859 661 432 651 312 0 0 0 0 0 0
Totale 20.470